Aida Perramon Malavez

Physics engineer with a touch of (pharmaco)epidemiology. PhD in Applied and Computational Physics (BIOCOM-SC, UPC). Postdoc at Erasmus MC on real-world evidence. I have yet to be convinced that a screen can catch a thought the way a page does.

Perramon-Malavez, A., Ye, Q., López, D. et al. Real-time prediction of influenza and respiratory syncytial virus epidemics in primary care using the Gompertz model. Sci Rep 16, 5763 (2026). DOI: 10.1038/s41598-026-36519-w

Coma, E., Martínez-Marcos, M., Hermosilla, E. et al. Impact of nirsevimab immunoprophylaxis on respiratory syncytial virus-related outcomes in hospital and primary care after two consecutive seasons: a population-based retrospective cohort study in infants in their second year of life in Catalonia, Spain. Eur J Pediatr 184, 616 (2025). DOI: 10.1007/s00431-025-06440-x

Perramon-Malavez, A.; Buonsenso, D.; Morello, R. et al. Real-world impact of nirsevimab immunisation against respiratory disease on emergency department attendances and admissions among infants: a multinational retrospective analysis. The Lancet Regional Health – Europe (2025). DOI: 10.1016/j.lanepe.2025.101334

Perramon-Malavez, A.; Hermosilla, E.; Coma, E. et al. Effectiveness of nirsevimab immunoprophylaxis against respiratory syncytial virus-related outcomes in hospital care settings: a seasonal cohort study of infants in Catalonia (Spain). Pediatr Infect Dis J (2025). DOI: 10.1097/INF.0000000000004672

Coma E, Martinez-Marcos M, Hermosilla E, et al. Effectiveness of nirsevimab immunoprophylaxis against respiratory syncytial virus-related outcomes in hospital and primary care settings: a retrospective cohort study in infants in Catalonia (Spain). Arch Dis Child 109, 736-741 (2024). DOI: 10.1136/archdischild-2024-327153

Perramon-Malavez, A., de Rioja, V.L., Coma, E. et al. Introduction of nirsevimab in Catalonia, Spain: description of the incidence of bronchiolitis and respiratory syncytial virus in the 2023/2024 season._ Eur J Pediatr _ 183, 5181–5189 (2024). DOI: 10.1007/s00431-024-05779-x

For a full list, see my ORCID profile.